Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kelfred Holdings's earnings before interest and taxes (EBIT) for the
six
months ended in Dec. 2025 was HK$-9.2 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-11.1 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Kelfred Holdings's annualizedROC % for the quarter that ended in Dec. 2025 was -14.76%.
Kelfred Holdings's annualizedROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -15.80%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Kelfred Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -14.24%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kelfred Holdings EBIT Related Terms
Kelfred Holdings EBIT Historical Data
* Premium members only.
The historical data trend for Kelfred Holdings's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Kelfred Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kelfred Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kelfred Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Kelfred Holdings's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-11.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kelfred Holdings (HKSE:01134) has a EBIT of HK$-11.1 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kelfred Holdings.
Is Kelfred Holdings' EBIT too high?
Kelfred Holdings' current EBIT is HK$-11.1 Mil. Overall, Kelfred Holdings has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kelfred Holdings' EBIT compare to ISRG and BDX?
Kelfred Holdings' EBIT of HK$-11.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kelfred Holdings. Kelfred Holdings's current EBIT is HK$-11.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelfred Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kelfred Holdings (HKSE:01134) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$0.24 — trading 45% below its estimated fair value. The current EBIT is HK$-11.1 Mil. Kelfred Holdings' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Kelfred Holdings (HKSE:01134), the current EBIT is HK$-11.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kelfred Holdings (HKSE:01134) Overvalued in 2026?
Based on GuruFocus' analysis, Kelfred Holdings stock appears to be undervalued.
The current stock price of HK$0.24 is trading 45% below its estimated GF Value™ of HK$0.44.
GuruFocus considers Kelfred Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01134:
EBIT: HK$-11.1 Mil
GF Value™: HK$0.44 vs. price of HK$0.24 (45% below fair value)
No single metric tells the full story. See the HKSE:01134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kelfred Holdings Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacturing and sales of eyewear products. It produces and sells a wide range of spectacle frames and sunglasses mainly through original design manufacturing (ODM) and original equipment manufacturing (OEM) business models. The group offers integrated and customised services, including product design and development, raw materials procurement, production, quality control, packaging, and delivery. The Group also offers (OBM) products under the brand name Miga. It operates in Italy, the United Kingdom, Hong Kong, the U.S., PRC, India, Spain, the Philippines, Japan, Australia, France, and other countries. It generates a majority of its revenue from the United Kingdom.
45GF Score
Get the complete analysis for HKSE:01134
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01134 has been successfully added to your 
